Loading...

Intracellular Staining Permeabilization Wash Buffer (10X)

Pricing & Availability
Regulatory Status
RUO
Other Names
Perm/Wash, Permeabilization Buffer
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
421002 100 mL 94 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Intracellular Staining Permeabilization Wash Buffer is useful for intracellular staining procedures, e.g., in preparation of cells for staining intracellular cytokines or other proteins. Intracellular Staining Permeabilization Wash Buffer is used to permeabilize cells following fixation with Intracellular Staining Fixation Buffer (Cat. No. 420801). It is supplied as a 10X solution and should be diluted in deionized water prior to use. Intracellular Staining Permeabilization Wash Buffer has been formulated to have minimal effects on cells, reduce non-specific staining and enhance the signal to noise ratio. It can be used for antibody dilutions and cell washing during intracellular staining.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
The Intracellular Staining Perm wash buffer solution should be stored between 2°C and 8°C. Do not freeze.
Application

ICC, ICFC - Quality tested
IHC - Reported in the literature, not verified in house
Recommended Usage

For use in permeabilization, dilute Intracellular Staining Permeabilization Wash Buffer (10X) to 1X in DI water. Resuspend fixed cells in diluted Intracellular Staining Permeabilization Wash Buffer and centrifuge at 350 xg for 5-10 minutes, and repeat the process twice. It is recommended that the reagent be titrated for optimal performance for each application. Please see "Intracellular Cytokine Staining Protocol" on BioLegend's website for more details.

Application Notes

The Intracellular Staining Permeabilization Wash Buffer (10X) may have crystallization or precipitation observed when it is stored at 2-8°C; however, this is normal and does not affect the buffer's performance. If there is heavy precipitation observed after dilution to 1X working solution, the buffer can be filtered to clarify the solution.

Application References

(PubMed link indicates BioLegend citation)
  1. Smeltz RB. 2007. J. Immunol. 178:4786.
  2. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  3. del Rio ML, et al. 2011. Transplantation. 92:1085. PubMed
  4. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
  5. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  6. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  7. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  8. Ni PP, et al. 2014. J Immunol. 193:1778. PubMed
Product Citations
  1. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  2. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  3. Kim S, et al. 2020. Development. 147:00:00. PubMed
  4. Dumauthioz N, et al. 2020. Cell Mol Immunol. . PubMed
  5. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
  6. Hanga MP, et al. 2021. Biotechnol Bioeng. 118:3175. PubMed
  7. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  8. Glaser K, et al. 2015. Immunol Lett. 166: 19-27. PubMed
  9. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  10. Khayrullina G, et al. 2020. Skelet Muscle. 10:16. PubMed
  11. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  12. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  13. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  14. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  15. Lebedeva IV, et al. 2021. Cell Death Dis. 12:770. PubMed
  16. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  17. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  18. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  19. Stewart CA, et al. 2020. bioRxiv. . PubMed
  20. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  21. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  22. Jacob A, et al. 2020. Nature Protocols. 14(12):3303-3332.. PubMed
  23. Stewart CA, et al. 2021. J Thorac Oncol. Online ahead of prin. PubMed
  24. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  25. Poli V, et al. 2021. iScience. 24:103256. PubMed
  26. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  27. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  28. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  29. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  30. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  31. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  32. Goyal S, et al. 2017. Sci Rep. . 10.1038/s41598-017-18046-x. PubMed
  33. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  34. Gärtner F, et al. 2021. Front Immunol. 12:745132. PubMed
  35. Gao F, et al. 2021. Front Cell Infect Microbiol. 10:593805. PubMed
  36. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  37. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  38. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  39. Shinde MY, et al. 2017. J Biol Chem. 292:18240. PubMed
  40. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  41. Ghose J, et al. 2018. Oncoimmunology. 7:e1486948. PubMed
  42. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  43. Lau H, et al. 2021. Int J Mol Sci. 22:. PubMed
  44. Zhou H, et al. 2022. J Clin Invest. 132:. PubMed
  45. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  46. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  47. Sohrabi Y, et al. 2020. Front Immunol. 11:353. PubMed
  48. Martinez–Usatorre A, et al. 2018. J Immunol. 201:792. PubMed
  49. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  50. Lau H, et al. 2021. Xenotransplantation. 28:e12667. PubMed
  51. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  52. Ma Q, et al. 2022. Nat Commun. 13:4142. PubMed
  53. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  54. Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed
  55. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  56. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  57. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  58. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  59. Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed
  60. Clancy–Thompson E, et al. 2018. Cancer Immunol Res. 1.308333333. PubMed
  61. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  62. Zhang X, et al. 2022. Theranostics. 12:1621. PubMed
  63. Berical A, et al. 2022. Nat Commun. 13:4270. PubMed
  64. Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed
  65. Baek J, et al. 2017. Am J Pathol. 10.1016/j.ajpath.2017.02.011. PubMed
  66. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  67. Rodriguez S, et al. 2020. Xenotransplantation. 27:e12554. PubMed
  68. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  69. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  70. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  71. Lownik JC, et al. 2019. J Immunol. 202:664. PubMed
  72. Lau H, et al. 2020. Xenotransplantation. 27:e12555. PubMed
  73. Mkhikian H, et al. 2022. Nat Aging. 2:231. PubMed
  74. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  75. Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed
  76. Nausch N, et al. 2017. PLoS Negl Trop Dis. 11(2):e0005415. PubMed
  77. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  78. Breznik JA, et al. 2018. Physiol Rep. 6:e13937. PubMed
  79. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  80. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  81. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  82. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  83. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  84. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  85. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  86. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  87. Page N, et al. 2021. Nat Commun. 12:1009. PubMed
  88. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  89. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  90. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  91. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  92. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  93. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  94. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  95. Hayes D, et al. 2022. JCI Insight. 7:. PubMed
  96. Gong C, et al. 2021. Mol Cell. 81:4059. PubMed
  97. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  98. Kim S, et al. 2020. Development. . PubMed
  99. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  100. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  101. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  102. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  103. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  104. Ma K, et al. 2022. iScience. 25:104347. PubMed
  105. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  106. Lau H, et al. 2020. Islets. 41:12. PubMed
  107. Lau H, et al. 2020. PLoS One. 15:e0243506. PubMed
  108. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  109. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  110. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  111. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  112. Haswell JR, et al. 2021. PLoS One. 16:e0252848. PubMed
  113. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  114. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  115. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  116. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  117. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  118. Spiliopoulou P, et al. 2022. Mol Cancer Ther. . PubMed
  119. Tintos-Hernandez JA, et al. 2021. Brain Commun. 3:fcab215. PubMed
  120. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  121. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  122. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  123. Gao J, et al. 2022. Front Immunol. 13:955812. PubMed
  124. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  125. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  126. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  127. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  128. Sun X, et al. 2017. Microbes Infect. 10.1016/j.micinf.2017.08.007. PubMed
  129. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  130. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  131. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  132. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  133. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  134. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  135. Lee G, et al. 2021. Viruses. 13: . PubMed
  136. Hernandez AA, et al. 2020. J Immunol. 205:2806. PubMed
  137. Su Y, et al. 2020. Cell. 1479:183. PubMed
  138. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  139. Mcgaw C, et al. 2022. Nat Commun. 13:2833. PubMed
  140. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  141. Zheng L, et al. 2020. Clin Cancer Res. 26:3694. PubMed
  142. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  143. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  144. Giadone RM, et al. 2018. Amyloid. 25:148. PubMed
  145. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  146. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  147. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  148. Wang X, et al. 2022. Elife. 11:. PubMed
  149. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  150. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  151. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  152. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  153. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  154. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  155. Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed
  156. Assadi G, et al. 2016. PLoS One. 11:e0168276. PubMed
  157. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  158. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  159. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  160. Luvanda MK, et al. 2021. J Fungi (Basel). 7:. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID
NA
Go To Top Version: 3    Revision Date: 08.26.2015

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account